Interim Results from CompLEEment-1 (A Phase IIIb Study of Ribociclib and Letrozole As First-Line Therapy for Advanced Breast Cancer in an Expanded Population): Spanish Cohort Results
ANNALS OF ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要